抗体与对自然HIV感染的抵抗力。 - Suppr

Suppr

超能文献

Antibodies and resistance to natural HIV infection.

作者信息

Nabel G J, Sullivan N J

机构信息

National Institutes of Health, Bethesda, MD 20892-3005, USA.

出版信息

N Engl J Med. 2000 Oct 26;343(17):1263-5. doi: 10.1056/NEJM200010263431711.

DOI:10.1056/NEJM200010263431711

PMID:11071680

Abstract

摘要

相似文献

Antibodies and resistance to natural HIV infection.抗体与对自然HIV感染的抵抗力。

N Engl J Med. 2000 Oct 26;343(17):1263-5. doi: 10.1056/NEJM200010263431711.

Humoral immunity to HIV, SIV, and SHIV.对HIV、SIV和SHIV的体液免疫

AIDS. 1998;12 Suppl A:S121-32.

Fc receptor but not complement binding is important in antibody protection against HIV.Fc受体而非补体结合在抗体抗HIV保护中起重要作用。

Nature. 2007 Sep 6;449(7158):101-4. doi: 10.1038/nature06106.

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.IgG1亚型的人源中和单克隆抗体可预防黏膜猿猴-人类免疫缺陷病毒感染。

Nat Med. 2000 Feb;6(2):200-6. doi: 10.1038/72309.

Prospects for vaccine protection against HIV-1 infection and AIDS.预防HIV-1感染和艾滋病的疫苗保护前景。

Annu Rev Immunol. 2002;20:73-99. doi: 10.1146/annurev.immunol.20.081501.094854. Epub 2001 Oct 4.

Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection.用源自HIV-1 SF162的包膜糖蛋白gp140进行免疫接种，并不能保护猕猴免受异源猿猴-人类免疫缺陷病毒SHIV89.6P的感染。

Virology. 2006 Jun 5;349(2):276-89. doi: 10.1016/j.virol.2006.01.043. Epub 2006 Mar 9.

CTL ontogeny and viral escape: implications for HIV-1 vaccine design.细胞毒性T淋巴细胞的个体发生与病毒逃逸：对HIV-1疫苗设计的启示

Trends Immunol. 2004 Mar;25(3):138-42. doi: 10.1016/j.it.2004.01.004.

Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies.羊水相对于血浆具有更高水平的慢病毒特异性抗体，并且可能含有中和抗体。

J Clin Virol. 2004 Nov;31(3):190-7. doi: 10.1016/j.jcv.2004.03.010.

Primate models of AIDS vaccine development.艾滋病疫苗开发的灵长类动物模型。

AIDS. 1997;11 Suppl A:S121-6.

Nonhuman primate models for HIV vaccine development.用于HIV疫苗研发的非人灵长类动物模型。

Immunodefic Rev. 1992;3(3):247-60.

引用本文的文献

Current situation in the development of a preventive HIV vaccine.预防性HIV疫苗的研发现状

Enferm Infecc Microbiol Clin. 2005 Jul;23:15-24. doi: 10.1016/S0213-005X(05)75157-0. Epub 2009 Jan 6.

HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies.面向非洲的艾滋病毒/艾滋病疫苗：科学机遇、挑战与策略

Pan Afr Med J. 2015 Apr 20;20:386. doi: 10.11604/pamj.2015.20.386.4660. eCollection 2015.

Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis.抗V3抗体F425-B4e8的中和广度分析及通过扫描诱变对其表位精细特异性的重新评估。

Virology. 2007 Aug 1;364(2):441-53. doi: 10.1016/j.virol.2007.03.007. Epub 2007 Apr 6.

Current situation in the development of a preventive HIV vaccine.预防 HIV 疫苗的发展现状。

Enferm Infecc Microbiol Clin. 2005 Jul;23 Suppl 2:5-24. doi: 10.1016/S0213-005X(05)75156-9.

Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies.1型人类免疫缺陷病毒/猴免疫缺陷病毒DNA疫苗引发的细胞免疫不会增强被动输注中和抗体所提供的无菌保护。

J Virol. 2003 Oct;77(19):10348-56. doi: 10.1128/jvi.77.19.10348-10356.2003.

Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design.人免疫缺陷病毒1型（HIV-1）单体gp120的高糖基化突变体作为HIV疫苗设计的新型抗原。

J Virol. 2003 May;77(10):5889-901. doi: 10.1128/jvi.77.10.5889-5901.2003.

Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.中和及非中和单克隆抗体与人免疫缺陷病毒1型gp120的CD4结合位点相互作用的精细定位

J Virol. 2003 Jan;77(1):642-58. doi: 10.1128/jvi.77.1.642-658.2003.

Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases.静脉注射免疫球蛋白在传染病预防或治疗中的应用。

Clin Diagn Lab Immunol. 2001 Sep;8(5):859-63. doi: 10.1128/CDLI.8.5.859-863.2001.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验